US pharmaceutical tariff impact: Who gained popularity and why -medical news

If you impose tariffs on goods that should be imported regularly, the price should rise. India’s major pharmaceutical manufacturers say that this is the basic economy of the workplace. He said he didn’t want to be nominated, and it would develop in the pharmaceutical sector that posted tariffs from April 2, he said.^ndBut the US pharmaceutical market is a bit more complicated. Cardinal Health, CENCORA & MCKESSON (three people who control most of the US pharmaceutical distribution market are clearly controlled), and there are at least 300 general pharmaceutical suppliers in India.

All eyes are currently in the appetite of suppliers (Indian drug manufacturers) and buyers (major US drug distributors) and absorb prices after the US tariff. The US pharmaceutical market is important, competitive and complicated. Indian companies, which are already responding to price erosion every year, also meet 40 %of the demand for generic pharmaceuticals in the United States.

India is important. McKinsey’s new report has emerged as the largest generic drug supplier in the United States as of 2024, as of 2024, and has emerged as the world’s largest generic drug supplier, including 25 %in the United States, and accounted for 20 %of the world’s amount, including 25 %of KingDom’s drugs. This report describes India as the third largest global exporters of pharmaceuticals and 11th place.^th Value. This country has a 752 FDA approval site. India’s constraints are 5 %of the world’s average patching, with an export growth rate of 9 %.

Indian companies are also operating in the competitive generic pharmaceutical market. In the United States, Indian companies are already facing a price erosion of about 5 %each year (at least some of the above). Therefore, the traditional argument is that the wholesaler and higher margin distributors are in a better position to absorb prices due to tariffs. But how many sellers can order the seller in the buyer market, there is no choice but also to be hit. So now it depends on how the numbers are played and how much they are willing to hit each. But what is inevitable for many people is that the final price of American medicines should rise mainly with the question of the increase.

Aditya khemka, ACC

What kind of medicine are we talking about in discussions where the final price increases? KHEMKA said, “The existence of Indian companies is generally powerful in oral solid and dermatology products (such as creams and ointments). Therefore, the drug in question can come from diabetes, hypertension or pain -related drugs.